NCT01852812View on ClinicalTrials.gov

Study of the Safety and Pharmacokinetics of Montelukast (MK-0476) in the Treatment of Japanese Pediatric Participants With Perennial Allergic Rhinitis (MK-0476-520)

PHASE3CompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

June 7, 2013

Primary Completion Date

December 24, 2013

Study Completion Date

December 24, 2013

Conditions
Perennial Allergic Rhinitis
Interventions
DRUG

Montelukast Oral Granules (OG)

Montelukast 4 mg in one sachet

DRUG

Montelukast Chewable Tablets (CT)

Montelukast 5 mg in one tablet

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT01852812 - Study of the Safety and Pharmacokinetics of Montelukast (MK-0476) in the Treatment of Japanese Pediatric Participants With Perennial Allergic Rhinitis (MK-0476-520) | Biotech Hunter | Biotech Hunter